Substituted 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-ones as potential antiinflammatory agents
摘要:
A series of analogues based on the 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one ring system have been synthesized and shown to possess oral antiinflammatory activity in both the reverse passive Arthus reaction (RPAR) pleural cavity assay in rats and in the adjuvant-induced arthritic rat model (AAR). Several members of this series additionally exhibit an inhibitory effect on the in vivo production of prostaglandin- and leukotriene-derived products or arachidonic acid metabolism although these compounds exhibit no significant inhibitory activity against the cyclooxygenase and 5-lipoxygenase enzymes in vitro. Structure-activity relationships in this series are discussed.
HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY
申请人:SCHERING CORPORATION
公开号:EP0419561A1
公开(公告)日:1991-04-03
3,3'-DISUBSTITUTED-1,3-DIHYDRO-2H-PYRROLO 2,3-b]HETEROCYCLIC-2-ONE USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS OF MAN
申请人:THE DU PONT MERCK PHARMACEUTICAL COMPANY
公开号:EP0660833A1
公开(公告)日:1995-07-05
US5182289A
申请人:——
公开号:US5182289A
公开(公告)日:1993-01-26
US5278162A
申请人:——
公开号:US5278162A
公开(公告)日:1994-01-11
[EN] HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY
申请人:SCHERING CORPORATION
公开号:WO1989012637A1
公开(公告)日:1989-12-28
(EN) Heterobicyclic and heterocyclic intermediate compounds and their use in treating inflammation, hyperproliferative skin conditions such as psoriasis and allergy are disclosed.(FR) L'invention concerne des composés intermédiaires hétérobicycliques hétérocycliques ainsi que leur utilisation dans le traitement anti-inflammatoire d'états cutanés hyperprolifératifs tels que le psoriasis et l'allergie.